Straumann Holding AG (OTCMKTS:SAUHY – Get Free Report) has been assigned an average rating of “Hold” from the seven analysts that are covering the firm, Marketbeat Ratings reports. Two equities research analysts have rated the stock with a sell rating, two have issued a hold rating and three have issued a buy rating on the company.
A number of research analysts recently issued reports on the company. Deutsche Bank Aktiengesellschaft restated a “buy” rating on shares of Straumann in a research note on Tuesday, June 30th. BMO Capital Markets assumed coverage on Straumann in a research note on Wednesday, July 8th. They issued an “outperform” rating for the company. Barclays reissued an “overweight” rating on shares of Straumann in a report on Thursday, June 18th. Citigroup restated a “sell” rating on shares of Straumann in a research report on Thursday, July 9th. Finally, Morgan Stanley reaffirmed an “underweight” rating on shares of Straumann in a report on Tuesday, June 30th.
Read Our Latest Report on Straumann
Straumann Trading Down 1.7%
About Straumann
Straumann (OTCMKTS:SAUHY) is a Swiss-based dental technology company that develops, manufactures and markets restorative, regenerative and digital solutions for dental professionals. The company’s core offerings center on implant-supported restorations and components, biomaterials used for bone and soft-tissue regeneration, and a range of prosthetic products used by dentists and dental laboratories to restore oral function and aesthetics.
In addition to implant and biomaterial product lines, Straumann provides digital dentistry solutions that support treatment planning and workflows.
Read More
- Five stocks we like better than Straumann
- AST SpaceMobile Stock Sinks as SpaceX Fallout Rattles Space Sector
- Aehr Test Systems Stock Soars on Earnings, Eyes Over 150% Revenue Growth
- TSMC Just Gave AI Chip Bulls Another Reason to Stay Confident
- GE Aerospace Faces a Prove-It Moment in Q2 Earnings
Receive News & Ratings for Straumann Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Straumann and related companies with MarketBeat.com's FREE daily email newsletter.
